BCKDK and ovarian cancer: However, in both breast and ovarian cancer cells, knockdown of BCKDK with each of the siRNA increased the caspase-3/7 activity induced by paclitaxel compared to cells transfected with a non-targetting siRNA (Fig. 2c).